Impact Biomedical Inc IBO
$0.43
▲ +0.00%
(+$0.00)
🗓️ Earnings Next Week
Open
$0.43
Prev Close
$0.43
Day Range
$0.43 – $0.44
52W Range
$0.37 – $0.83
Market Cap
$46.36M
Beta
-1.05
EPS (TTM)
$-1.26
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NYSE MKT LLC |
| Currency | USD |
| IPO Date | 2024-09-16 |
| Shares Out. | 107,820,000 |
| Website | impactbiomedinc.com/ ↗ |
| Phone | 15852321500 |
| Employees | 8 |
| Revenue | $7,000 |
| Gross Profit | $7,000 |
| Net Income | -$2.3M |
| Total Assets | $17.1M |
| Total Liabilities | $2.4M |
| Equity | $14.7M |
About Impact Biomedical Inc
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.
Impact Biomedical Inc is a publicly traded company under the ticker symbol IBO on the NYSE MKT LLC, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.